Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") today announced that analyses of the initial Phase 3 program of ampreloxetine (Studies 169 and 170) will be presented at the ...

Commvault, a leading provider of cyber resilience and data protection solutions for the hybrid cloud, today announced highly differentiated capabilities with its Cleanroom Recovery offering that usher ...